Swine fever
African swine fever: an unprecedented disaster and challenge to China
5
The role of proteolytic processing of the 220kDa polyprotein of African swine fever virus and aggresomes during virion assembly
274
Substitution of Specific Cysteine Residues in the E1 Glycoprotein of Classical Swine Fever Virus Strain Brescia Affects Formation of E1-E2 Heterodimers and Alters Virulence in Swine
9
N-Linked Glycosylation Status of Classical Swine Fever Virus Strain Brescia E2 Glycoprotein Influences Virulence in Swine
10
Recombinant Antigen Targets for Serodiagnosis of African Swine Fever
9
English Pig Farmers' Knowledge and Behaviour towards African Swine Fever Suspicion and Reporting
13
African swine fever: a global view of the current challenge
14
The evolution of African swine fever (ASF) in Europe and our country
13
African Swine Fever Virus Is Wrapped by the Endoplasmic Reticulum
15
The E2 Glycoprotein of Classical Swine Fever Virus Is a Virulence Determinant in Swine
10
Biosynthesis of Classical Swine Fever Virus Nonstructural Proteins
14
Purification and properties of African swine fever virus.
8
Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins.
8
A Proteomic Atlas of the African Swine Fever Virus Particle
18
The African Swine Fever Virus Thymidine Kinase Gene Is Required for Efficient Replication in Swine Macrophages and for Virulence in Swine
6
Comparison of African Swine Fever Virus Prevalence in Nigerian Indigenous Pig, Its Hybrid and Backcross in an Environment Prone to African Swine Fever
10
Interferon-Inducible Oligoadenylate Synthetase-Like Protein Acts as an Antiviral Effector against Classical Swine Fever Virus via the MDA5-Mediated Type I Interferon-Signaling Pathway
14
Estimating the Basic Reproductive Number for African Swine Fever Using the Ukrainian Historical Epidemic of 1977
27
Crystal Structure of African Swine Fever Virus dUTPase Reveals a Potential Drug Target
11
A decade of research into classical swine fever marker vaccine CP7_E2alf (Suvaxyn® CSF Marker): a review of vaccine properties
10